Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fait

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Casopis Lekaru Ceskych|December 12, 2007
[Changes of plasminogen activator inhibitor (PAI-1) during estrogen replacement therapy]Z Zizka, T Fait, M Vrablík
Ceska Gynekologie|May 26, 1998
[Importance of determination of activated protein C resistance (APC) in gynecology and obstetrics]T Fait, Z Vorlová, J Zivný
Ceska Gynekologie|November 25, 2016
[Spontaneus delivery after two previous caesarean sections - case report]P Šašková, T Fait, Z Žižka
Climacteric : the Journal of the International Menopause Society|October 9, 2018
The use of estradiol metered-dose transdermal spray in clinical practiceT Fait, A Fialova, Z Pastor
Ceska Gynekologie|August 1, 2009
[Uterine torsion--the rare compliation of pregnancy]Jana Skrenková, T Fait, A Dolezal
Ceska Gynekologie|January 8, 2016
[Nine-valent HPV vaccine - new generation of HPV vaccine]T Fait, V Dvořák, R Pilka
Casopis Lekaru Ceskych|August 23, 2006
[Changes in C-reactive protein levels induced by different application forms of estrogen replacement therapy]T Fait, M Vrablík, M Kostírová, et al.
Ceska Gynekologie|September 13, 2013
[Recommendations for prescribing combined hormonal contraceptives]V Unzeiting, P Čepický, V Dvořak, et al.
Ceska Gynekologie|January 8, 2008
[Determination concentrations of tissue factor pathway inhibitor and their changes during estrogen replacement therapy]T Fait, B Trnková, M Kostírova, et al.
Ceska Gynekologie|March 9, 2019
Eating disorders in pregnancyM Kníže, Z Baraníková, V Krejčová, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Casopis Lekaru Ceskych|December 12, 2007
[Changes of plasminogen activator inhibitor (PAI-1) during estrogen replacement therapy]Z Zizka, T Fait, M Vrablík
Ceska Gynekologie|May 26, 1998
[Importance of determination of activated protein C resistance (APC) in gynecology and obstetrics]T Fait, Z Vorlová, J Zivný
Ceska Gynekologie|November 25, 2016
[Spontaneus delivery after two previous caesarean sections - case report]P Šašková, T Fait, Z Žižka
Climacteric : the Journal of the International Menopause Society|October 9, 2018
The use of estradiol metered-dose transdermal spray in clinical practiceT Fait, A Fialova, Z Pastor
Ceska Gynekologie|August 1, 2009
[Uterine torsion--the rare compliation of pregnancy]Jana Skrenková, T Fait, A Dolezal
Ceska Gynekologie|January 8, 2016
[Nine-valent HPV vaccine - new generation of HPV vaccine]T Fait, V Dvořák, R Pilka
Casopis Lekaru Ceskych|August 23, 2006
[Changes in C-reactive protein levels induced by different application forms of estrogen replacement therapy]T Fait, M Vrablík, M Kostírová, et al.
Ceska Gynekologie|September 13, 2013
[Recommendations for prescribing combined hormonal contraceptives]V Unzeiting, P Čepický, V Dvořak, et al.
Ceska Gynekologie|January 8, 2008
[Determination concentrations of tissue factor pathway inhibitor and their changes during estrogen replacement therapy]T Fait, B Trnková, M Kostírova, et al.
Ceska Gynekologie|March 9, 2019
Eating disorders in pregnancyM Kníže, Z Baraníková, V Krejčová, et al.
Pageof 7